[Sumatriptan 3â¯mg subcutaneous : Clinical relevance of acute treatment of migraine despite dose reduction]. / Sumatriptan 3â¯mg subkutan : Klinische Relevanz in der Akuttherapie der Migräne trotz Dosisreduktion.
Nervenarzt
; 93(6): 612-617, 2022 Jun.
Article
in De
| MEDLINE
| ID: mdl-34557933
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sumatriptan
/
Migraine Disorders
Type of study:
Diagnostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
De
Journal:
Nervenarzt
Year:
2022
Document type:
Article
Country of publication: